Orion Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.4K Hold
619
0.02% 291
2026
Q1
$53.6K Hold
619
0.02% 256
2025
Q4
$59.5K Buy
+619
New +$60.1K 0.02% 259
2024
Q3
Sell
-180
Closed -$14.2K 312
2024
Q2
$14.2K Sell
180
-2,000
-92% -$164K 0.01% 339
2024
Q1
$190K Sell
2,180
-760
-26% -$64.9K 0.1% 128
2023
Q4
$242K Sell
2,940
-1,805
-38% -$138K 0.14% 107
2023
Q3
$372K Sell
4,745
-1,695
-26% -$142K 0.24% 81
2023
Q2
$567K Sell
6,440
-400
-6% -$34.4K 0.37% 57
2023
Q1
$551K Sell
6,840
-200
-3% -$16.3K 0.37% 54
2022
Q4
$547K Hold
7,040
0.4% 51
2022
Q3
$568K Sell
7,040
-1,200
-15% -$108K 0.46% 48
2022
Q2
$740K Sell
8,240
-1,000
-11% -$101K 0.57% 39
2022
Q1
$1.02M Buy
9,240
+60
+0.7% +$6.34K 0.62% 39
2021
Q4
$950K Buy
9,180
+230
+3% +$26.6K 0.54% 47
2021
Q3
$1.12M Hold
8,950
0.68% 39
2021
Q2
$1.11M Buy
8,950
+120
+1% +$15.1K 0.69% 40
2021
Q1
$1.04M Buy
8,830
+50
+0.6% +$5.86K 0.73% 37
2020
Q4
$1.03M Buy
+8,780
New +$967K 0.76% 38

Other funds holding MDT

Orion Capital Management's MDT Position: Q2 2026 in Review

Orion Capital Management held its Medtronic (MDT) position steady in Q2 2026 at 619 shares worth $48.4K. The position accounts for 0.02% of the portfolio, ranked #291.

Orion Capital Management first reported a position in MDT in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.12M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Orion Capital Management held 619 shares of Medtronic worth $48.4K as of Q2 2026.
  • Orion Capital Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.02% of Orion Capital Management's portfolio in Q2 2026, its #291 holding.
  • Orion Capital Management first reported a position in Medtronic in Q4 2020 and has held it in 18 quarters since.
  • Orion Capital Management's Medtronic position peaked at $1.12M in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.